Nadolol

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 76282-347
  • Package NDC 76282-347-01
  • Application number ANDA203455
  • SPL ID 21acaed7-dd88-4da4-a60a-bbc9c33cadac
  • SPL set ID 5c6737f8-8fd8-4d8f-a66a-e99d3b64e1dd
  • UNII FEN504330V
  • RxCUI 198006
  • RxCUI 198007
  • RxCUI 198008

What the source publishes

Labeler
Exelan Pharmaceuticals Inc.
Active ingredients
Nadolol
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:76282-347_21acaed7-dd88-4da4-a60a-bbc9c33cadac
{
  "name": "Nadolol",
  "splId": "21acaed7-dd88-4da4-a60a-bbc9c33cadac",
  "labels": [
    {
      "setId": "5c6737f8-8fd8-4d8f-a66a-e99d3b64e1dd",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c6737f8-8fd8-4d8f-a66a-e99d3b64e1dd",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5c6737f8-8fd8-4d8f-a66a-e99d3b64e1dd"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Exelan Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (76282-347-01)",
      "package_ndc": "76282-347-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200727"
    }
  ],
  "productId": "76282-347_21acaed7-dd88-4da4-a60a-bbc9c33cadac",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "76282-347",
  "deaSchedule": null,
  "genericName": "Nadolol",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NADOLOL",
      "strength": "20 mg/1"
    }
  ],
  "applicationNumber": "ANDA203455",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200727",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000000161",
      "N0000175556"
    ],
    "upc": [
      "0376282347011",
      "0376282348018"
    ],
    "unii": [
      "FEN504330V"
    ],
    "rxcui": [
      "198006",
      "198007",
      "198008"
    ],
    "spl_set_id": [
      "5c6737f8-8fd8-4d8f-a66a-e99d3b64e1dd"
    ],
    "pharm_class_epc": [
      "beta-Adrenergic Blocker [EPC]"
    ],
    "pharm_class_moa": [
      "Adrenergic beta-Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Exelan Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:76282-347_21acaed7-dd88-4da4-a60a-bbc9c33cadac"